ANI Pharmaceuticals, Inc.
ANIP
$97.10
$1.902.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.48% | 252.60% | 57.48% | -956.67% | -112.56% |
| Total Depreciation and Amortization | 1.70% | 1.29% | 43.51% | 7.15% | 0.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 257.76% | -142.54% | 23.59% | -1.78% | 316.16% |
| Change in Net Operating Assets | 2,626.56% | 116.60% | -169.31% | 356.43% | 55.94% |
| Cash from Operations | 116.66% | 120.62% | 27.14% | -28.37% | -4.68% |
| Capital Expenditure | -62.25% | -3.34% | 50.25% | -8.16% | 2.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | 97.91% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 83.34% | -20,100.00% | 86.37% | -- | -- |
| Cash from Investing | 65.19% | -85.81% | 97.32% | -8,857.56% | -149.80% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 0.00% | -1,201.92% | 99.95% | -39,150.00% | 0.00% |
| Issuance of Common Stock | -50.99% | 49.06% | 42.62% | 18.61% | -61.21% |
| Repurchase of Common Stock | 94.49% | -3,045.60% | 53.24% | 47.69% | 84.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.25% | 0.00% | 0.00% | 0.25% | -0.25% |
| Other Financing Activities | -- | -- | 89.76% | -- | 100.00% |
| Cash from Financing | 82.36% | -101.87% | -101.69% | 20,143.39% | 92.64% |
| Foreign Exchange rate Adjustments | 383.16% | 24.81% | -426.67% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,275.90% | 4,117.89% | 99.87% | -925.96% | 54.00% |